Envoy Medical Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $39K-15.2% YoYTTM through 31 Mar 2026
Net Income -$4.4MTTM through 31 Mar 2026
Margins
| Current | |
|---|---|
| Operating Margin | -15,279.5% |
| Net Margin | -11,156.4% |
Returns
-42.8%ROE
-14.6%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio2.27x
Net Debt-$25.3Mnet cash position
Cash & Equivalents$25.3M
Quality Metrics
Earnings-Beat Rate33.3%
Dividend
No dividend
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Hearing | $39K | -15.2% | View detailsDevelopment efforts are focused on the investigational fully implanted Acclaim cochlear implant, which completed pivotal trial enrollment in March 2026. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.